Production (Stage)
ESSA Pharma Inc.
EPIX
$1.67
-$0.03-1.77%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.37M | -8.53M | -6.36M | -7.23M | -8.99M |
| Total Depreciation and Amortization | 24.00K | 23.40K | 22.80K | 22.70K | 22.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 993.90K | 2.44M | 2.68M | 2.08M | 1.20M |
| Change in Net Operating Assets | -1.49M | -399.40K | 290.10K | -618.80K | 946.60K |
| Cash from Operations | -6.85M | -6.47M | -3.37M | -5.75M | -6.82M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -153.90K | -3.93M | 21.02M | 23.50K | 62.51M |
| Cash from Investing | -153.90K | -3.93M | 21.02M | 23.50K | 62.51M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 59.70K | 25.60K | 643.60K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | 59.70K | 25.60K | 643.60K |
| Foreign Exchange rate Adjustments | -- | -- | 6.50K | -1.90K | 4.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.00M | -10.40M | 17.72M | -5.70M | 56.34M |